
CRISPR for better cell therapies @Stanford PhD 🌲 · @UCBerkeley 🐻 Stanley Qi & Crystal Mackall labs
Joined July 2021
- Tweets35
- Following111
- Followers125
- Likes136
Pinned Tweet
🗣️wahoo!!! my doctoral work is out online in @CellCellPress: authors.elsevier.com/c/1ie1V…!! couldn't have done it without my two wonderful labs and co-advisors @stanleyqilab & @MackallLab
we developed a new RNA-targeting CRISPR platform (MEGA) to engineer better T cell therapies...🧵
so grateful for the opportunity to highlight our work on multiplexed transcriptome engineering & combinatorial screening for better CAR T cell therapies in the latest issue of @NatureRevCancer!!
📄: rdcu.be/dHbjn
Victor Tieu retweeted
We’re still in our BRAT summer by sharing our new RNA resources! Improved understanding of RNA over the years has led to huge developments, such as creating a COVID vaccine that saved millions of lives. Learn more in our new fact sheet! genome.gov/about-genomics/ed…
yes!! i've long suspected that this was the case since essentially all prior cas13d collateral cleavage studies were done in transfected cell lines. it's so great to see this important & rigorous study out – congrats to the team!!
🚨New lab preprint! 🚨
A deep dive to shed light on a long-standing controversy with RNA-targeting CRISPRs: Do they have high levels of collateral (trans) cleavage of other RNAs in the cell ✂️✂️✂️ — or not?
New work from talented PhD student #SydneyHart & others in our lab. 📰
5
397
Victor Tieu retweeted
Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations go.nature.com/3UTnSXM
Victor Tieu retweeted
Bidirectional epigenetic editing reveals hierarchies in gene regulation go.nature.com/4apFU9q
Victor Tieu retweeted
Nature research paper: Engineered CD47 protects T cells for enhanced antitumour immunity go.nature.com/4bl7dmG
thanks @GenomeSeminars @harvardmed for inviting me to give a talk on MEGA recently!! really great opportunity for young scientists/first authors to present & discuss their work. seminars are weekly, totally free to attend (zoom), and recorded/posted here: gess.hms.harvard.edu
8
350
!!!!!
Beyond excited to share that my project from @MackallLab and @StanfordMed, led by my incredible postdoc-turned-PI @EvanWeberPhD, in collaboration with his new(ish) lab at @ChildrensPhila, is now published in Nature! Check it out here:
nature.com/articles/s41586-0…
1
246
Victor Tieu retweeted
In summary, memory programming (but not TOO much memory) is a great thing for CAR T! FOXO1 is critical for mediating CAR T function and FOXO1 overexpression represents a broadly-applicable approach to enhance CAR T antitumor activity. The jury is still out on TCF1/TCF7. 13/
Victor Tieu retweeted
Check out the latest findings from PICI Center Director at @StanfordMed Crystal Mackall, MD, @MackallLab. The PICI-funded research suggests cell therapies for #cancer could see improvements with use of a new CRISPR RNA-editing platform called MEGA. Learn more in @CellCellPress
SCI members Stanley Qi, Crystal Mackall & team pioneered MEGA, a #CRISPR RNA-editing tool enhancing #CARTcells precision against tumors. stanford.io/3TdepLd @stanleyqilab @MackallLab
wow!! thank you @ACIR_org & lauren hitchings for the wonderful writeup and visual summary of our work!!
MEGA is a CRISPR-Cas13d system that allows for knockdown of gene expression at the genetic level, offering several unique advantages over CRISPR-Cas9 👉 acir.org/weekly-digests/2024… @StanfordMed
Victor Tieu retweeted
Lead author Victor Tieu, @stanleyqilab, Crystal Mackall @MackallLab & team discovered a way to potentially improve CAR T therapies using a CRISPR RNA-editing platform—Multiplexed Effector Guide Arrays (MEGA)—that boosts the cells’ ability to target tumors stanford.io/49LV20X
Victor Tieu retweeted
A CRISPR-Cas13d based platform MEGA enables safer, more controllable editing of T cells to enhance CAR T therapy via reversible, multiplexed gene knockdown without cutting genomic DNA. #NBThighlight
cell.com/cell/abstract/S0092…
Victor Tieu retweeted
SCI members Stanley Qi, Crystal Mackall & team pioneered MEGA, a #CRISPR RNA-editing tool enhancing #CARTcells precision against tumors. stanford.io/3TdepLd @stanleyqilab @MackallLab
big thanks to @Nature for featuring our work!!
A CRISPR-based system that edits RNA rather than DNA can give new life to exhausted CAR T cells go.nature.com/49ms485
8
440
Victor Tieu retweeted
Now online! A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells dlvr.it/T35n3V
Victor Tieu retweeted
New work led by Victor Tieu @victortieu & collaboration with Dr. Crystal Mackall, in Cell @CellCellPress, for T cell transcriptome & metabolic engineering for a better cancer therapy. news.stanford.edu/2024/02/21…
so what does this all mean?
1) metabolic engineering is a great way to enhance CAR T cell function
2) MEGA does this better than state-of-the-art methods
3) aerobic glycolysis & T cell exhaustion are linked
4) in vitro assays (e.g. cytokine) often don't give us the full picture!
























